Myocarditis in patients with antisynthetase syndrome: Prevalence, presentation, and outcomes

Medicine (United States)

Volumn 94, Issue 26, 2015, Pages

  Dieval, Céline ^a   Deligny, Christophe ^b   Meyer, Alain ^c   Cluzel, Philippe ^d   Champtiaux, Nicolas ^e   Lefevre, Guillaume ^f   Saadoun, David ^e   Sibilia, Jean ^c   Pellegrin, Jean Luc ^g   Hachulla, Eric ^f   Benveniste, Olivier ^e   Hervier, Baptiste ^e  

^a Centre Hospitalier de Rochefort   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE FORT DE FRANCE   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^d Service de Radiologie Vasculaire et Interventionnelle   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; ANGIOTENSIN ANTAGONIST; ANTIARRHYTHMIC AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATINE KINASE; CYCLOPHOSPHAMIDE; DIURETIC AGENT; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INOTROPIC AGENT; MYCOPHENOLATE MOFETIL; TROPONIN I; TROPONIN T;

ADOLESCENT; ADULT; AGED; ANTISYNTHETASE SYNDROME; ARTICLE; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIA; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FUNCTION; HUMAN; HYPERTENSION; INOTROPISM; INTENSIVE CARE; INTERSTITIAL PNEUMONIA; MALE; MIDDLE AGED; MYOCARDITIS; NEW YORK HEART ASSOCIATION CLASS; OBESITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERICARDITIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SMOKING HABIT; TACHYCARDIA; THORAX PAIN; TRANSTHORACIC ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE; YOUNG ADULT; COMPLICATION; FRANCE; MYOSITIS; PREVALENCE;

ADOLESCENT; ADULT; AGED; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; MYOCARDITIS; MYOSITIS; PREVALENCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84942531769     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000798     Document Type: Article

References (20)

1. Marguerie C, Bunn CC, Beynon HL, et al. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med. 1990;77:1019-1038.
2. Hervier B, Devilliers H, Stanciu R, et al. Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity. Autoimmun Rev. 2012;12:210-217.
3. Lundberg IE. The heart in dermatomyositis and polymyositis. Rheumatology. 2006;45:iv18-iv21.
4. Van Gelder H, Charles-Schoeman C. The heart in inflammatory myopathies. Rheum Dis Clin North Am. 2014;40:1-10.
5. Hervier B, Meyer A, Dieval C, et al. Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival. Eur Respir J. 2013;42:1271-1282.
6. Labirua-Iturburu A, Selva-O'Callaghan A, Vincze M, et al. Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature. Medicine. 2012;91:206-211.
7. Brady S, Melath S, Scalco RS, et al. Fatal cardiac involvement complicating antisynthetase syndrome. BMJ Case Rep. 2014;25:pii: bcr2014204409.
8. Sharma K, Orbai AM, Desai D, et al. Brief report: antisynthetase syndrome-associated myocarditis. J Card Fail. 2014;20:939-945pii: S1071-9164(14)00685-X.
9. Cooper LT Jr. Myocarditis. N Engl J Med. 2009;360:1526-1538.
10. Sagar S, Liu PP, Cooper LT Jr. Myocarditis. Lancet. 2012;379:738-747.
11. Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol. 2007;50:1914-1931.
12. Lurz P, Eitel I, Adam J, et al. Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis. JACC Cardiovasc Imaging. 2012;5:513-524.
13. Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol. 2009;53:1475-1487.
14. Lauer B, Niederau C, Kühl U, et al. Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol. 1997;30:1354-1359.
15. Smith SC, Ladenson JH, Mason JW, et al. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation. 1997;95:163-168.
16. Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2009;34:1219-1263.
17. Gupta R, Wayangankar SA, Targoff IN, et al. Clinical cardiac involvement in idiopathic inflammatory myopathies: a systematic review. Int J Cardiol. 2011;148:261-270.
18. Morgera T, Di Lenarda A, Dreas L, et al. Electrocardiography of myocarditis revisited: clinical and prognostic significance of electro-cardiographic changes. Am Heart J. 1992;124:455-467.
19. D'Ambrosio A, Patti G, Manzoli A, et al. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart. 2001;85:499-504.
20. Zhang L, Wang GC, Ma L, et al. Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review. Clin Cardiol. 2012;35:686-691.